Cytokinesis failure leads to the emergence of tetraploid cells and multiple centrosomes. Chronic lymphocytic leukaemia (CLL) is the most common haematological malignancy in adults and is characterized by clonal B cell expansion. Here, we show that a significant number of peripheral blood CLL cells are arrested in cytokinesis and that this event occurred after nuclear envelope reformation and before cytoplasmic abscission. mRNA expression data showed that several genes known to be crucial for cell cycle regulation, checkpoint and centromere function, such as ING4, ING5, CDKN1A and CDK4, were significantly dysregulated in CLL samples. Our results demonstrate that CLL cells exhibit difficulties in completing mitosis, which is different from but may, at least in part, explain the previously reported accumulation of CLL cells in G0/1.
| INTRODUCTION
Chronic lymphocytic leukaemia (CLL) is characterized by clonal expansion of mature CD5+CD19+CD23+ B lymphocytes that accumulate in the bone marrow and lymphoid tissue, such as spleen and lymph nodes. Initially, CLL was considered to result from the accumulation of long-lived, but resting lymphocytes; however, recent evidence points to the presence of a pool of proliferating B cells. 1 Clinically, CLL is a very heterogeneous disease; many patients require no therapy and show an asymptomatic disease, while other patients suffer from a rapidly progressing disease despite treatment.
Although therapy has been improved and has led to prolonged survival, CLL remains incurable and many patients eventually relapse. 2 Chronic lymphocytic leukaemia is characterized by copy number variation and deletion events affecting chromosomes 6q, 11q, 13q and 17p. Chromosomal deletions are used as prognostic markers with the loss of the long arm of chromosome 13 (13q-) being the most common aberration indicating good prognosis. Patients harbouring the 13q deletion usually live for many years without the need for therapy, while patients with a deletion of the short arm of chromosome 17 (17p-) often require treatment and have a particularly poor prognosis and overall shortest survival of all CLL patients. 3, 4 Cytokinesis is the final step of cell division ending with the physical separation into 2 daughter cells. It starts after chromosome segregation in anaphase during mitosis, with the cleavage furrow formation at the equatorial cortex ingressing inwards to divide the mother cell, and ending with the physical detachment of the 2 daughter cells. This process involves a series of spatio-temporal regulated events ensuring an equal distribution of genomic and cytoplasmic material between the 2 nascent daughter cells. 5 Cytokinesis failure leads to the emergence of tetraploid cells and multiple centrosomes, 6, 7 although the underlying mechanism of this phenomenon remains incompletely understood. It is thought that numerical aberrations (aneuploidy) that are frequently found in tetraploid cells are connected to the presence of multiple centrosomes that block spindle geometry and, as a result, interfere with accurate chromosome segregation. 7 In this study, we report that a significant number of CLL cells are arrested in cytokinesis. Immunohistochemistry staining for known mitosis exit markers such as Tubulin, Actin and Polo-like kinase 1 (Plk1) was used to demonstrate that CLL cell doublets are retained at the stage of mitotic exit with multiple centrosomes in interphase.
Moreover, we found that expression levels of several genes known to regulate mitotic exit and centrosome function were significantly reduced in CLL samples. Importantly, the described cytokinesis defect is distinct from the previously reported accumulation of cells in G0/1. 
| MATERIALS AND METHODS

| Isolation of CD19+ cells
. Samples from at least 3 independent healthy donors and indicated number of CLL patient samples were used for each target gene and run in technical triplicate. Values were normalized to the reference gene hARP
| RNAseq
Candidate genes involved in the described cytokinesis defect were identified based on a list of differentially expressed genes from a previously analysed, publically available RNAseq data set based on a cohort of 98 CLL patients and healthy donor controls 9 (European Genome-Phenome Archive, under accession number EGAS000 01000374). In Ferreira et al, 9 genes were considered differentially expressed when showing absolute fold change (Tumour/Normal) ≥ 2 with false discovery rate (FDR) < 0.01. 
| Statistical analysis
For all statistical analyses in the manuscript, t test was used. Quantitative data are presented as average AE SEM, and differences with P ≤ .05 using t test were considered significant. and DAPI staining, we demonstrated that the nuclear envelope was closed and chromosomes were decondensed ( Figure 1B) ; however, in CLL doublet cells the cytoplasm was interconnected ( Figure 1A ).
When we performed immunofluorescence staining for Plk1 and Aurora B, proteins known to regulate cytokinesis, 11, 12 we found that Plk1 localized at the cytokinesis contractile ring in CLL doublets ( Figure 1C ), which is a hallmark of cytokinesis. 11 Taken together, our results indicate that CLL cell doublets were in the cytokinesis stage of the cell cycle, specifically, after reformation of the nucleus, but before abscission and physical separation of the cytoplasm.
11,13-16
To investigate whether CLL doublets can complete cytokinesis, we co-cultured them on CD40L feeder cells and performed live cell imaging. We observed that CLL doublets fluctuate back and forth and remained interconnected, a phenomenon we could not find in healthy donor cells (Figure 2A and proteasome activator complex subunit 3 (PSME3) (fc = Figure 3A and Supporting Information). In addition, genes encoding proteins involved in centrosome assembly and function such as centromere protein T (CENPT) (fc = 2.94) and centromere protein J (CENPJ) (fc = 2.08) were up-regulated in CLL compared to healthy samples ( Figure 3A) . Moreover, expression levels of cyclin-dependent kinase 4 (CDK4) (fc = 2.08), cell cycle division cycle protein 16 homolog (CDC16) (fc = 3.81) and cyclindependent kinase 2-associated protein (CDK2AP) (fc = 2.69), which are involved in centrosome duplication, [23] [24] [25] were increased in CLL compared to healthy samples ( Figure 3A and Supporting Information). Next, we performed qRT-PCR analysis to verify that genes involved in cell cycle regulation were also dysregulated in the CLL samples used to analyse the cytokinesis defect on a cellular level. Shown are genes involved in centrosome assembly, duplication and regulation as well as genes regulated by TP53. qRT-PCR analyses on the indicated number of CLL vs healthy control (n = 3) samples demonstrated significant differences in mRNA expression levels for (B) CDK4 (*P ≤ .05), (C) ING4 (*P ≤ .05), (D) ING5 (*P ≤ .05), (E) TP53I3 (**P ≤ .005) and (F) CDKN1A/p21 (**P ≤ .005) healthy donor samples. Taken together, we found several genes known to play a role in cell cycle regulation altered in CLL.
| Basal TP53 expression levels were significantly altered in CLL samples
The heatmaps shown in Figure 3A contain several genes that encode proteins known to play a role in cell cycle control and to interact with TP53. As reduced TP53 levels have also been associated with accumulation of cells in cytokinesis, 25, 26 we examined a potential link between TP53 dysregulation and the observed cytokinesis defect. In all analysed CLL samples, we found significantly reduced TP53 protein ( Figure 4A ,C) and reduced mRNA expression levels compared to healthy donor samples (Supporting Information). In one CLL sample, we could not detect any TP53, and in 2 of 9 analysed CLL samples, TP53 migrated higher, which can possibly be explained by post-translational modifications ( Figure 4A ). While it has previously been shown that TP53 is dysregulated in CLL cells, 27 to the best of our knowledge, we are the first to compare basal protein levels of TP53 between CLL and healthy donor CD19+ cells.
| NuMA protein levels were reduced in CLL patient samples
Proteomics analysis performed on a subset of CLL samples indicated that NuMA protein expression levels might be altered in CLL (data not shown). As NuMA is known to be required for proper assembly and maintenance of the mitotic spindle, and non-functional NuMA has been shown to cause defects in mitosis exit and inability to complete cytokinesis, 28, 29 we analysed NuMA protein levels in our cohort of CLL samples. Indeed, we found a significant reduction (50%) of NuMA in 8 of 9
analysed CLL compared to 5 healthy donor samples ( Figure 4A,B) .
In addition, we detected cytoplasmic leakage of NuMA in CLL samples, while this was not the case in healthy donor samples ( Figure 4D,E) . These results further support that CLL cells exploit mitosis defects since under physiological conditions, NuMA localizes to the nucleus during interphase and is dispersed throughout the cytoplasm during mitosis. reduced NuMA and TP53 levels may contribute to the cytokinesis defects described in this study.
| DISCUSSION
In the present study, we report for the first time that a significant number of CLL cells are arrested in cytokinesis. CLL cells exhibit supernumerary centrosomes and decreased expression levels of genes encoding proteins involved in cell cycle regulation and mitotic progression such as CENPO, PSME3 and CDKN1A. In contrast, genes encoding CDC16, CDK4 and CENPT, which are known to be involved in centrosome assembly and duplication, were increased in CLL samples.
The evidence that CLL cells were arrested in cytokinesis is based on Actin, Tubulin and Plk-1 staining of a joint cytoplasmic bridge, which is distinct from the previously described overrepresentation of cells in the G0/1 cell cycle phase. The described Actin, Tubulin and Plk1 localization corresponds to late steps of cytokinesis, more precisely, to the step after nuclear envelope reformation and chromosome decondensation, but before cytoplasmic abscission by the contractile ring between the 2 daughter cells. 11, [13] [14] [15] [16] Previous studies have linked cytokinesis defects, multiple centrosomes and accumulation of cells in G0/1 to be a consequence of dysregulation of important players in cell cycle regulation. 34 Centrosome amplification can be induced via deregulation of the centrosome duplication process in interphase [35] [36] [37] [38] [39] [40] [41] [42] [43] or through mitotic defects resulting in G0/1 cells with tetraploid cells. 44 The latter can be experimentally induced by overexpression of Plk1, Aurora A and Aurora B. 41, 44 Our data also indicate that centrosome aberrations in malignant cells can arise via mitotic defects. The described cytokinesis failure leading to cells that harbour supernumerary centrosomes resembles the findings described for overexpression of Plk1, Evi1, Aurora A and Aurora B.
41,44
The TP53 pathway has been extensively studied in CLL, and chromosomal aberrations such as deletion of 17p13 are known to cause loss of TP53 function. 45 In addition, decreased TP53 expression and activity independent of 17p13 deletions have been associated with deletion of the ATM gene, which increases MDM2 activity and in turn leads to decreased TP53 pathway activity 45, 46 .
In the present study, we detected significantly reduced basal TP53
protein levels in all analysed CLL samples, although only 2 of the 20 patients included in our study are known to harbour a TP53 mutation. Down-regulation of TP53 is known as one cause to bypass anaphase checkpoint and DNA damage response during mitosis exit, which under normal conditions is active and prevents NuMA is important for maintenance of the mitotic spindle, and non-functional NuMA has been shown to cause defects in mitosis exit and completion of cytokinesis. 28, 29 These studies support our finding that reduced NuMA levels may contribute to the cytokinesis arrest described in the present study. Previous studies performing
RNAi-mediated knockdown linked reduced NuMA protein levels to reduced CDKN1A (p21) mRNA expression levels, while it does not affect expression of TP53 regulated pro-apoptotic genes. 28 , 29 We also showed that CDKN1A expression levels were reduced in CLL compared to healthy donor samples, while pro-apoptotic genes such as TP53I3, ING4 and ING5 were increased.
One key characteristic of CLL, as assessed by flow cytometrybased analysis is the accumulation of clonal B cells arrested in the early G0/1 phase of the cell cycle. 47, 48 A possible explanation why the cytokinesis defect described here has not previously been reported is that conventional flow cytometry does not easily distinguish between cells in the G1 or cytokinesis part of the cell cycle and that a majority of cells in cytokinesis are counted as G1 cells because of the break of the cytoplasmic bridge. 49 In conclusion, our results provide novel insights into the cell cycle dysregulation that occurs in CLL. Centrosome amplification, secondary to a cytokinesis defect, might be one important contributing factor to chromosomal instability in CLL. Additionally, it may be a critical 
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